Patients Already in Biohaven Epilepsy Trials Keep Dosing as FDA Pauses New Enrollment Over a Rodent FindingWorldNewsHub24September 11, 2026 The Food and Drug Administration has paused new patient enrollment in trials of opakalim, an experimental epilepsy drug also known…
